OncoSec Medical to Present at the 15th Annual Rodman & Renshaw Global Investment Conference

SAN DIEGO – September 4, 2013 — OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, has announced it will be presenting at the Annual Rodman & Renshaw 2013 Global Investment Conference in New York City.

Punit Dhillon, President and CEO of OncoSec Medical, will provide a company overview and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

The presentation will take place on Monday, September 9 at 2:25 PM ET at Room 7.02, 7th Floor of the Millennium Broadway Hotel in New York, NY. The presentation will also be webcast and can be viewed at this link: http://wsw.com/webcast/rrshq23/ONCS. The webcast replay will remain available for 90 days following the live presentation.